GRDX GridAI Technologies posts wider than expected Q3 2024 per share loss stock falls 109 in todays session Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia UMH Properties UMH climbs 142 percent even after posting a large Q4 2025 earnings miss relative to analyst estimates